Serum miR-4530 sensitizes breast cancer to neoadjuvant chemotherapy by suppressing RUNX2

PURPOSE: Neoadjuvant chemotherapy (NAC) plays a pivotal role in the treatment of locally advanced breast cancer (LABC); however, breast cancer is a heterogeneous disease, individual responses to chemotherapy are highly variable. Therefore, the purpose of the current research is to identify biomarker...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiao-Xiao, Ye, Fu-Gui, Zhang, Jie, Li, Jun-Jing, Chen, Qing-Xia, Lin, Pei-Yang, Song, Chuan-Gui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188109/
https://www.ncbi.nlm.nih.gov/pubmed/30349372
http://dx.doi.org/10.2147/CMAR.S172205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188109/
https://www.ncbi.nlm.nih.gov/pubmed/30349372
http://dx.doi.org/10.2147/CMAR.S172205

Ejemplares similares